Effective portfolio and trial oversight is essential to ensure that all studies are managed consistently, are of high quality and are kept on track. Recent global events coupled with the general industry shift to a risk-based quality management approach for clinical trials have demanded a new outlook on trial management.

Inhaled studies are often perceived as technically challenging, and varied regulations around the world add another level of complexity.

Bird's eye view of the new automated kit production line, now open for EMEA investigator sites at our European Operations Center.

Recent increases in regulatory scrutiny and focus emphasize the importance of quality antibody reagents. The majority of biotherapeutic programs have several critical reagents that require generation, storage/management and periodic retesting.

Seamless solutions help keep your trials on track

Clinical trial journey with our patient-centric model

Learn how Functional Service Provider (FSP) models can best support sponsor-directed processes in Decentralized Clinical Trials (DCT).

Your source for answers to the complex challenges of cell and gene therapy development.

Learn from Steven M Anderson, PhD, Chief Scientific Officer, Labcorp Drug Development, in our on-demand, English-subtitled webinar that discusses trends in precision medicine, various approaches and the commercialization of biomarker companion diagnostic assays.

The global pandemic has accelerated the need to modernize clinical trials via a virtual (decentralized) framework.